Ulrich Otte is the Senior Vice President of Marketing & Patient Solutions at Novo Nordisk Inc. A strategic leader with over 25 years of diverse business and financial experience, he is responsible for guiding the US strategy and execution of Novo Nordisk’s cardiometabolic portfolio. In this role, he oversees a team focused on improving health outcomes for millions of people who can benefit from Novo Nordisk medicines in the US, including delivering a best-in-class experience for patients and healthcare providers.

Ulrich joined Novo Nordisk in 2000 as the Financial Controller for Corporate Accounting in Copenhagen, Denmark. He has held roles of increasing responsibility, including Corporate Vice President of Product Supply Global Investment and Finance, and Corporate Vice President of Corporate Financial Planning.

In 2017, Ulrich joined the Novo Nordisk US leadership team as the Senior Vice President of Finance, Insights, and Enterprise Solutions for Novo Nordisk Inc. He was responsible for Finance and Supply Chain Management, Procurement and Business Solutions, as well as Pricing, Contract Operations, and Reimbursement. In addition to his financial management responsibilities, his team led Enterprise Insights, Enterprise Data and Advanced Analytics, Digital, Data and IT, and worked to improve patient outcomes through Patient Support Solutions.

Before joining Novo Nordisk in the US, Ulrich was the Corporate Vice President of Finance for Novo Nordisk China, where he led a diverse team supporting market access, government and public affairs, finance, information technology, procurement, and Hong Kong commercial operations.

He began his career as an Audit Manager at PricewaterhouseCoopers. Ulrich holds a Master of Science in Business, Economics, and Auditing from Copenhagen Business School.